# Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease

> **NCT02193048** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 216 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **OTHER:** This study will evaluate a new clinical scoring system in patients receiving routine treatment

## Key facts

- **NCT ID:** NCT02193048
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2024-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193048, "Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02193048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*